Immunogenicity and safety of two novel human papillomavirus 4- and 9-valent vaccines in Chinese women aged 20–45 years: A randomized, blinded, controlled with Gardasil (type 6/11/16/18), phase III non-inferiority clinical trial

Author:

Shu Yajun,Yu Yebin,Ji Ying,Zhang Li,Li Yuan,Qin Haiyang,Huang Zhuhang,Ou Zhiqiang,Huang Meilian,Shen Qiong,Li Zehong,Hu Meng,Li Chunyun,Zhang Gaoxia,Zhang Jikai

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference45 articles.

1. Immunogenicity and safety of a tetravalent dengue vaccine and a bivalent HPV vaccine given concomitantly or sequentially in girls aged 9 to 14 years in Mexico;Arredondo;Vaccine,2021

2. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

3. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis;De Martel;Lancet Glob Health,2020

4. World Health Organization. Human Papillomavirus (HPV) and Cervical Cancer. (Updated on February 22, 2022). https://www.who.int/news-room/fact-sheets/detail/cervical-cancer. Accessed on July 26, 2022.

5. Trends of incidence rate and age at diagnosis for cervical cancer in China, from 2000 to 2014;Li;Chin J Cancer Res,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3